The North America Gastrointestinal Products Market was valued at $5720 Million in 2024 and projected to reach to $7826.3 Million by 2029, representing a compound annual growth rate of 6.5%. North America's gastrointestinal products market is positioned for sustained expansion through 2029, supported by rising incidence of GI disorders, increased consumer awareness, and continuous innovation in treatment modalities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America's gastrointestinal products market reached $5,720 million in 2024 and is projected to expand to $7,826.3 million by 2029, driven by a robust 6.5% CAGR, outpacing the global growth rate of 6.1%.
North America's aging demographic profile significantly drives demand for gastrointestinal products, as older populations experience higher prevalence of digestive disorders, acid reflux, and inflammatory bowel conditions requiring ongoing treatment.
The region benefits from elevated healthcare expenditure and strong insurance coverage, enabling widespread adoption of advanced gastrointestinal therapeutics, diagnostic tools, and over-the-counter remedies across both clinical and consumer segments.
The United States represents the largest market within North America at $3,663.9 million, accounting for approximately 64% of the regional market, with Canada contributing $458.4 million to the overall regional growth trajectory.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | IRRITABLE BOWEL SYNDROME (IBS) (Disease) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 6.1% from 2024 to 2029 |
| Largest Segment | ENDOSCOPY DEVICES (Device) |
| Market Size Base Year (Billions) | ~USD 14.65 (2024) |
| Revenue Forecast (Billions) | ~USD 19.7 (2029) |
| Segments Covered | Device, Type, Disease, End User |
4 segment dimensions are covered across the global market.
| Country | 2025 size (native) |
|---|---|
| US | USD 3663.9 Million |
| Canada | USD 458.4 Million |
North America's gastrointestinal products market was valued at $5,720 million in 2024.
North America's gastrointestinal products market is projected to reach $7,826.3 million by 2029.
North America's gastrointestinal products market is expected to grow at a compound annual growth rate of 6.5% from 2024 to 2029.
North America's market growth is driven by rising gastrointestinal disorder prevalence, aging demographics, advanced healthcare infrastructure, increased consumer awareness, and strong reimbursement frameworks.
North America is significant due to its advanced healthcare systems, high product adoption rates, robust reimbursement policies, strong innovation pipelines, and substantial healthcare spending on digestive health solutions.
The study involved four major activities to estimate the current size of the gastroenterology products market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Gastrointestinal Products Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Extensive primary research was conducted after obtaining information regarding the Gastroenterology Products Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the gastrointestinal products market.; and key opinion leaders.
Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market. the following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure
The research methodology used to estimate the size of the gastrointestinal products market includes the following details. The market sizing of the market was undertaken from the global side.
The size of the gastrointestinal products market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall gastrointestinal products market was obtained from secondary data and validated by primary participants to arrive at the total gastroenterology products market. Primary participants further validated the numbers.
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Gastroenterology/Gastrointestinal Products Market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.


To know about the assumptions considered for the study, Request for Free Sample Report
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the gastrointestinal products market.
Gastroenterology products encompass a variety of medical devices, diagnostic tools, and pharmaceuticals designed to diagnose, treat, and manage diseases and disorders of the gastrointestinal tract. These products include endoscopes, capsule endoscopy systems, ablation devices, stents, and specialized medications aimed at conditions like GERD, IBD, and colorectal cancer. Their purpose is to improve patient outcomes by offering advanced solutions for both diagnostic and therapeutic procedures within the GI tract.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Gastrointestinal Products Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report